Oral squamous cell carcinomas: state of the field and emerging directions
Oral squamous cell carcinoma (OSCC) develops on the mucosal epithelium of the oral
cavity. It accounts for approximately 90% of oral malignancies and impairs appearance …
cavity. It accounts for approximately 90% of oral malignancies and impairs appearance …
Cancer stem cells as key drivers of tumour progression
AZ Ayob, TS Ramasamy - Journal of biomedical science, 2018 - Springer
Abstract Background Cancer stem cells (CSCs) are subpopulations of cancer cells sharing
similar characteristics as normal stem or progenitor cells such as self-renewal ability and …
similar characteristics as normal stem or progenitor cells such as self-renewal ability and …
Cancer stem cell (CSC) resistance drivers
M Najafi, K Mortezaee, J Majidpoor - Life sciences, 2019 - Elsevier
Cancer stem cells (CSCs) are a population of self-renewal cells with high tumorigenic
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …
Cancer drug resistance induced by EMT: novel therapeutic strategies
J De Las Rivas, A Brozovic, S Izraely, A Casas-Pais… - Archives of …, 2021 - Springer
Over the last decade, important clinical benefits have been achieved in cancer patients by
using drug-targeting strategies. Nevertheless, drug resistance is still a major problem in …
using drug-targeting strategies. Nevertheless, drug resistance is still a major problem in …
Targeting epithelial–mesenchymal transition (EMT) to overcome drug resistance in cancer
Epithelial–mesenchymal transition (EMT) is known to play an important role in cancer
progression, metastasis and drug resistance. Although there are controversies surrounding …
progression, metastasis and drug resistance. Although there are controversies surrounding …
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …
Update on epithelial-mesenchymal plasticity in cancer progression
R Fontana, A Mestre-Farrera… - Annual Review of …, 2024 - annualreviews.org
Epithelial-mesenchymal transition (EMT) is a cellular process by which epithelial cells lose
their characteristics and acquire mesenchymal traits to promote cell movement. This …
their characteristics and acquire mesenchymal traits to promote cell movement. This …
[HTML][HTML] Stability of the hybrid epithelial/mesenchymal phenotype
Abstract Epithelial-to-Mesenchymal Transition (EMT) and its reverse–Mesenchymal to
Epithelial Transition (MET)–are hallmarks of cellular plasticity during embryonic …
Epithelial Transition (MET)–are hallmarks of cellular plasticity during embryonic …
Partial EMT in head and neck cancer biology: a spectrum instead of a switch
Our understanding of epithelial-to-mesenchymal transition (EMT) has slowly evolved from a
simple two state, binary model to a multi-step, dynamic continuum of epithelial-to …
simple two state, binary model to a multi-step, dynamic continuum of epithelial-to …
[HTML][HTML] Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Epithelial-mesenchymal transition (EMT) is a cellular biological process involved in
migration of primary cancer cells to secondary sites facilitating metastasis. Besides, EMT …
migration of primary cancer cells to secondary sites facilitating metastasis. Besides, EMT …